(Q45287872)

11 December 2017

Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

2

1 reference

11 December 2017

3

1 reference

11 December 2017

Anna de Lang

1

1 reference

PubMed ID

16860835

11 December 2017

language of work or name

English

0 references

publication date

24 July 2006

1 reference

11 December 2017

1 reference

11 December 2017

353

1 reference

11 December 2017

2

1 reference

11 December 2017

474-481

1 reference

Angiotensin-converting enzyme 2--a new cardiac regulator

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Treatment of SARS with human interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Angiotensin-converting enzyme 2 is an essential regulator of heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

ACE2 gene expression is up-regulated in the human failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

An interferon-gamma-related cytokine storm in SARS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Angiotensin-converting enzyme 2 protects from severe acute lung failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

IL-4 Suppresses the Expression and the Replication of Hepatitis B Virus in the Hepatocellular Carcinoma Cell Line Hep3B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Lung pathology of fatal severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Murine IL-4 antagonizes the protective effects of IFN on virus-mediated lysis of murine L929 fibroblast cells.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16860835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interleukin-4 causes delayed virus clearance in influenza virus-infected mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16860835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.06.011

1 reference

11 December 2017

0 references

1 reference

PubMed ID

16860835